Catheter shaft and associated devices, systems, and methods

Information

  • Patent Grant
  • 11433218
  • Patent Number
    11,433,218
  • Date Filed
    Monday, December 19, 2016
    8 years ago
  • Date Issued
    Tuesday, September 6, 2022
    2 years ago
Abstract
Catheter shafts and associated devices, systems, and methods are disclosed herein, A representative catheter in accordance with an embodiment of the disclosure includes a generally tubular outer structure and an inner structure surrounded by the outer structure. The inner structure surrounds a catheter lumen. The inner structure includes over-lapping edges such that, when the catheter is bent along its longitudinal axis, the over-lapping edges move relative to one another.
Description
TECHNICAL FIELD

The present technology is directed generally to catheters. More specifically, the present technology relates to catheter shaft construction.


BACKGROUND

A wide variety of medical devices have been developed for intravascular use. Catheters, for example, are commonly used to facilitate navigation through and/or treatment within the anatomy of a patient. Because of the compromises involved between the mechanical, biological and chemical requirements for catheter performance, many existing catheters are a composite of two or more different materials in order to take advantage of the unique properties of the different materials. For example, a common composite catheter construction includes (1) an outer jacket made of a material that provides longitudinal rigidity to resist, kinks and (2) a chemically-inert inner surface liner (typically a fluoropolymer) having a low coefficient of friction to ease delivery of one or more components through the shaft lumen. Inner liner materials, however, are significantly less flexible than the materials used for the outer jacket, and thus greatly affect the flexibility of the composite catheter shaft. For example, the modulus of elasticity of materials commonly used as inner surface liners is about 70,000 psi, while the modulus of elasticity for common outer jacket material(s) is about 2,900 psi. Although some conventional catheters are made with low durometer polymers, e.g., extremely soft), such catheters generally have little kink resistance. Accordingly, a need exists for a kink-resistant catheter shall with improved flexibility.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a side view of a portion of a catheter shaft configured in accordance with the present technology, shown in an unstressed state.



FIG. 1B is a cross-sectional view of the catheter shaft shown in FIG. 1A, taken along line 1B-1B.



FIG. 1C is an isolated, isometric view of an inner structure of the catheter shaft shown in FIGS. 1A-1B configured in accordance with the present technology.



FIG. 1D is an enlarged view of a portion of the cross-sectioned catheter shall shown in FIG. 1B.



FIG. 2A is an isometric view of the catheter shaft shown in FIGS. 1A-1C, shown bent along a curved axis.



FIG. 2B is a side view of the catheter shaft shown in FIG. 2A.



FIG. 2C is an isometric front view of the catheter shaft shown in FIGS. 2A and 2B.



FIG. 2D is a cross-sectional view of the catheter shaft shown in FIGS. 2A-2C taken along line 2D-2D of the view shown in FIG. 2C.



FIG. 2E is an enlarged view of a portion of the cross-sectioned catheter shaft shown in FIG. 2D.



FIG. 2F is an enlarged view of a portion of the cross-sectioned catheter shaft shown in FIG. 2D.



FIG. 3A is an isometric view of a catheter shaft configured in accordance with another embodiment of the present technology, shown bent along its axis.



FIG. 3B is a side view of the catheter shaft shown in FIG. 3A.



FIG. 4A is an isolated, isometric view of an inner structure of the catheter shaft shown in FIGS. 3A-3B configured in accordance with the present technology, shown in an unstressed state.



FIG. 4B is an isolated side view of the inner structure shown in FIG. 4A.



FIG. 4C is an isolated segment of the inner structure shown in FIGS. 4A-4B configured in accordance with the present technology.





DETAILED DESCRIPTION

The present technology is directed to catheters and associated methods of manufacture. Specific details of several embodiments of catheter devices, systems, and methods in accordance with the present technology are described below with reference to FIGS. 1A-4C. In one embodiment, the present technology includes a catheter shaft composed of a tubular outer structure and a helical inner structure surrounded by the outer structure. The inner structure can be formed of a strip of material wound around a central longitudinal axis such that the edges of the strip overlap to form a continuous tubular wall. In some embodiments, only an exposed portion of the strip defines an exterior surface of the continuous tubular wall. The exposed portion can be bonded to the outer structure while a remaining portion of the strip remains free to slide relative to the exposed portion. Accordingly, the catheter shaft of the present technology is significantly more flexible than a comparable shaft utilizing an inner structure made of a contiguous tube.


I. SELECTED EMBODIMENTS OF CATHETER SHAFTS


FIGS. 1A and 1B are side and cross-sectional views, respectively, of a portion of a composite catheter shaft 100 (also referred to herein as “the shaft 100”) configured in accordance with the present technology shown in an unstressed state. Referring to FIGS. 1A-1B together, the catheter shaft 100 includes a generally tubular sidewall 102 that defines a lumen 104 therethrough. The lumen 104 is configured to slidably receive and facilitate the passage therethrough of one or more medical devices, such as catheters, cannulas, access ports, guidewires, implants, infusion devices, stents and/or stem-grafts, intravascular occlusion devices, clot retrievers, stent retrievers, implantable heart valves, and other suitable medical devices and/or associated delivery systems. Additionally, the lumen 104 can be configured to receive one or more fluids therethrough, such as radiopaque dye, saline, drugs, and the like.


The size of the lumen 104 can vary depending on the desired characteristics of the shaft 100. For example, in some embodiments the shaft 100 can have an inner diameter (e.g., lumen diameter) between about 0.01 inches and about 0.5 inches, and in some embodiments between about 0.2 inches and about 0.4 inches. Although the shaft 100 shown in FIGS. 1A-1B has a generally round (e.g., circular) cross-sectional shape, it will be appreciated that the shaft 100 can include other cross-sectional shapes or combinations of shapes. For example, the cross-sectional shape of the shaft 100 can be oval, oblong, rectangular, square, triangular, polygonal, and/or any other suitable shape and/or combination of shapes.


As shown in FIGS. 1A-1B, the sidewall 102 of the shaft 100 includes an outer structure 114 and an inner structure 112 surrounded by the outer structure 114. An end portion of the outer structure 114 has been removed in FIGS. 1A-1B to better illustrate the structural features of the inner structure 112; generally, the outer structure 114 surrounds the inner structure 112 along the entire length of the inner structure 112. In some embodiments, the outer structure 114 can be an elongated polymer tube. Suitable materials for the outer structure 114 include Pebax® (poly ether block amide), polyoxymethylene (POM), polybutylene terephthalate (PBT), polyether block ester, polyether block amide (PEBA), fluorinated ethylene propylene (FEP), polyethylene (PE), polypropylene (PP), polyvinylchloride (PVC), polyurethane, polytetrafluoroethylene (PTFE), polyether-ether ketone (PEEK), polyimide, polyamide, polyphenylene sulfide (PPS), polyphenylene oxide (PPO), polysulfone, nylon, perfluoro(propyl vinyl ether) (PEA), polyether-ester, platinum, polymer/metal composites, etc., or mixtures, blends or combinations thereof.



FIG. 1C is an isolated isometric view of the inner structure 112 alone without the outer structure 114. As shown in FIGS. 1A-1C, the inner structure 112 can be a single strip 113 of material wound around a central longitudinal axis A such that the edges of the strip 113 overlap to form a continuous/contiguous (e.g., gap-free) tubular wall having a discontinuous exterior surface 125 in a longitudinal direction. The inner structure 112 and/or strip 113 can be made of a material having a low coefficient of friction, such as a fluoropolymer and/or a lubricious polymer (e.g., high density polyethylene (HDPE), polytetrafluoroethylene (PTFE), and/or a copolymer of tetrafluoroethylene with perfluoroethers such as perfluoroalkoxy (PEA), perfluoropropyl vinyl ether, and/or perfluoromethyl vinyl ether). Other suitable materials can include PEEK, PE, PP, or a copolymer of tetrafluoroethylene, FEP, etc. In many embodiments of the present technology, the inner structure material(s) has a higher melting point than the outer structure material(s).


As shown in the enlarged, cross-sectional view of the shaft 100 in FIG. 1D, the wound strip 113 has an overlapping region 122 that defines a subduction zone and a non-overlapping region 140. In the embodiment shown in FIGS. 1A-1D, a width of the overlapping region 122 is generally the same along the length of the shaft 100. In other embodiments, a width of the overlapping region 122 can vary along the length of the shaft 100. In a representative embodiment, when the shaft 100 is in an unstressed state, about 50% or less of the strip 113 covered. Such a configuration avoids gradually increasing a thickness of the inner structure 112 in a given longitudinal direction. In other embodiments, the percentage of overlap can be more than 50%. The amount of overlap (or pitch of a helical strip) may be varied along the length of the shaft to create regions of different and/or changing stiffness.


The overlapping region 122 includes an outer portion 124 of the strip 113 and an inner portion 126 of the strip 113 positioned radially inwardly of the outer portion 124, as shown in FIG. 1D. The outer portion 124, inner portion 126, and non-overlapping region 140 together define a width w of the strip 113. Additionally, a thickness of the inner structure 112 can be the sum of the thicknesses of the outer portion 124 and the inner portion 126 (labeled to and ti, respectively), or two times a thickness of the strip 113.


The outer portion 124 can have an outer surface 124a facing radially outwardly and an inner surface 124b opposite the outer surface 124a and facing the lumen 104. The inner portion 126 has an outer surface 126a facing radially outwardly and an inner surface 126b opposite the outer surface 126a and facing the lumen 104. In the embodiment shown in FIGS. 1A-1D, the outer surface 124a of the outer portion 124 is bonded or otherwise fixed to the outer structure 114 along all or a portion of the length of the outer portion 124. The shaft 100 can include a gap 118 between adjacent turns of the outer portion 124 and the outer structure 114. The inner surface 124b of the outer portion 124 abuts the outer surface 126a of the inner portion 126 along all or a portion of their respective lengths. Because the strip 113 is made of a material having a low coefficient of friction, the inner surface 124b of the outer portion 124 can contact the outer surface 126a of the inner portion 126, yet retain the ability to slide relative to the outer surface 126a (and vice versa) when the shaft 100 is bent along its axis A. Additionally, the inner surface 126b of the inner portion 126 can define the shaft lumen 104, as shown in FIG. 1D.



FIGS. 2A-2C are an isometric view, a side view, and an isometric front view, respectively, of the catheter shaft 100 in accordance with the present technology, shown bent along axis A (e.g., a curved axis upon bending). FIG. 2D is a cross-sectional view of the catheter shaft shown in FIGS. 2A-2C taken along line 2D-2D of the view shown in FIG. 2C, and FIGS. 2E and 2F are enlarged views of a portion of the cross-sectioned catheter shaft 100 shown in FIG. 2D. Referring to FIGS. 2A-2F together, when the shaft 100 bends or deforms, the outer structure 114 deforms elastically and threes the fixed outer portion 124 to move and bend with it. As the outer portion 124 moves, the inner portion 126 slides along the inner surface 124b of the outer portion 124. Along portions of the shaft 100 experiencing tensile forces, the width of the overlapping region 122 decreases, as shown in FIG. 2E. Along portions of the shaft 100 experiencing compressive forces, the width of the over-lapping region 122 increases, as shown in FIG. 2F, as the outer portion 124 subducts with respect to the inner portion 126.


The catheter shaft 100 of the present technology provides several advantages over existing catheters. For example, the helical or spiral geometry of the inner structure 112, as well as the inner structure's 112 interrupted bonding with the outer structure 114, greatly increases the overall flexibility of the inner structure 112 as compared to a continuous tube made of the same material and having the same thickness. As such, the catheter shaft 100 of the present technology is significantly more flexible than conventional catheter shafts. For example, in some embodiments, the bending stiffness of the shaft 100 may be 25% less than that of a comparable composite catheter shaft (e.g., a shaft having the same outer structure and an inner structure made of a continuous tube made of the same material, having the same thickness and the same inner diameter). In some embodiments, the bending stiffness may be between about 30% and about 60% less than that of a comparable composite catheter. In some embodiments, the inner structure may provide less than about 50%, and in other embodiments less than about 25%, of the total bending stiffness of the composite catheter. Such improved flexibility is most dramatic in larger diameter catheters (assuming wall thickness does not vary based on diameter), such as guide catheters. For a given bend radius and wall thickness, the walls of catheters with a large ID are subject to greater strain than the walls of small ID catheters.


II. SELECTED METHODS OF MANUFACTURE

In one embodiment of manufacturing a catheter shaft in accordance with the present technology, a strip of material is provided. In some embodiments, the strip can be made of the desired inner structure material, such as PTFE. The strip can be a PTFE tape, a longitudinally-cut PTFE tube (described in greater detail below), or other polymer structures in a strip form. For example, in some embodiments, the strip is constructed by splitting the wall of a polymer tube along a helical path about the tube's longitudinal axis. In any of the foregoing embodiments, the strip of material may be wound around a mandrel. In a representative embodiment, the strip is wound from the proximal end to the distal end such that the strips' free edges or steps face distally within the lumen. The strip can be wound in this manner to provide a smoother path through the lumen for one or more devices delivered therethrough. In other embodiments, the strip can be wound from its distal end to its proximal end.


The strip can be wound to have a desired pitch angle (e.g., the distance between successive turns of the strip). The pitch angle affects the flexibility of the resulting wound structure since the pitch angle affects the amount of overlapping regions per unit length of the shaft, which in turn affects the width of bonded strip that (eventually) undergoes bending stress. In some embodiments, the maximum pitch angle to achieve 50% coverage can be governed by the equation max pitch angle=tan−1(2πD/w), and the minimum pitch angle to achieve no overlap can be governed by the equation min pitch angle=tan−1(πD/w), where D is the desired inner diameter for the shaft and w is the width of the strip of material.


Once the strip is wound around the mandrel as desired, a tube of material (e.g., a polymer commonly used for the outer structure) is positioned over the wound strip. Next, a heat-shrinkable tube (e.g., a fluoropolymer) can be positioned over the tube. The assembly (e.g., the mandrel, the wound strip, the tube, and the heat-shrinkable tube) is then gradually heated from its distal end to its proximal end (or vice versa) to fuse the tube with the strip. The amount of calories absorbed by the assembly, and the rate at which the calories are transferred to the mandrel, will depend on the geometry of the assembly (e.g., the length of the assembly, the diameter of the assembly, the thickness of the materials used, etc.). The temperature can be high enough to shrink the heat-shrinkable tube and raise the temperature of the tube material above its glass transition temperature (e.g., between about 380° F. and about 440° F.), yet low enough so as not to affect the durometer of the tube material and affect its resultant molecular weight (thereby charging the mechanical properties of the resultant outer structure). Also, the duration of heat application can be monitored to avoid for applying too high of a temperature for too long, which may cause the tube material to flow between the overlapping portion of the strip and into the lumen thereby raising the coefficient of friction within the catheter lumen. Additionally, the mandrel material can be chosen to provide a heatsink to quickly remove heat from the melted tube and freeze it before the tube material flows between the overlaps. For example, in some embodiments the mandrel is a steel tube, and the wall thickness of the tube can be varied to add or subtract heat transfer rate. Once the assembly has cooled, the heat shrinkable tube can be removed and the newly-formed composite shaft can be removed from the mandrel.


In any of the devices and methods disclosed herein, the inner structure is formed of a polymer tube (e.g., a PTFE tube) that is cut into strips in a direction parallel to the longitudinal axis of the tube. The width of the strip is then (πD) where D is the tubing diameter. The thickness of the strip is the wall thickness of the tubing. Another method of creating strip from tubing is to slice the tube helically. The maximum width of the strip is then (πD)/(tan θ), where θ is the angle of the helix from the tube axis.


Before cutting the tube, the tube can be etched on only its exterior surface to increase the coefficient of friction between the exterior surface of the tube and other polymers (i.e., the outer structure material) that may be bonded to the exterior surface of the tube. The tubing may be etched with a strong base (e.g., sodium hydroxide, potassium hydroxide, sodium/ammonia, etc.) by immersing the tube in liquid etchant as an on-line process during extrusion, or as a batch process after extrusion. The latter method includes plugging the ends of the PTFE tubing before immersion or otherwise keeping the open ends out of the liquid etchant. This way, only one surface of the polymer tubing material is etched while the other surface is not etched.


III. ADDITIONAL EMBODIMENTS


FIGS. 3A and 3B are isometric and side views, respectively, of a catheter shaft 300 (also referred to herein as “the shaft 300”) configured in accordance with another embodiment of the present technology, shown bent along its axis A. As shown in FIGS. 3A and 3B, the shaft 300 can include an outer structure 314 and an inner structure 312 surrounded by the outer structure 314. FIGS. 4A and 4B are side and isometric views of the inner structure 312 isolated from the shaft 300. In the embodiment shown in FIGS. 3A-4B, the inner structure 312 is formed of a plurality of overlapping segments 315, such as rings. An isolated segment 315 is shown in FIG. 4C. The segments 315 can have a generally cylindrical or conical shape. Additionally, referring to FIG. 4B, individual segments 315 can have an outer portion 326 having an inner diameter and an inner portion 326 having an outer diameter that fits within the inner diameter of the outer portion 326. The segments 315 can be arranged as shown in FIG. 4B such that the inner portion 326 of one segment 315 is received within the outer portion 324 of an immediately adjacent segment 315. The inner portions 326 accordingly overlap the outer portions 324 in a manner similar to the embodiments described above with respect to FIGS. 1A-2F. The outer portions 326 are fixed to the outer structure 314, but inner portions 326 can slide over the inner surface of the outer portions 326. As a result, the shaft 300 is expected to have similar advantages to those described above with respect to the shaft 100.


IV. EXAMPLES

The following examples are illustrative of several embodiments of the present technology:


1. A catheter, comprising:

    • a generally tubular outer structure; and
    • an inner structure surrounded by the outer structure and that surrounds a catheter lumen.


2. The catheter of example 1, wherein the inner structure includes over-lapping edges.


3. The catheter of example 1 or example 2, wherein the inner structure is non-continuous in a longitudinal direction.


4. The catheter of any one of examples 1-3, wherein the inner structure has freely sliding interfaces with itself.


5. The catheter of any one of examples 1-4, wherein the inner structure provides less than 50% of the total bending stiffness of the catheter.


6. The catheter of any one of examples 1-5, wherein the inner structure has portions that slide tangentially during bending of the catheter.


7. A catheter, comprising

    • a generally tubular outer structure, the outer structure having an outer surface and an inner surface; and
    • an inner structure surrounded by the outer structure, the inner structure having a relaxed state and a stressed state, and wherein
      • the inner structure is composed of a strip of material that is helically wound around a central longitudinal axis to form a generally tubular member defining a lumen, wherein the strip has an outer surface and an inner surface,
      • a first portion of the strip overlaps a second portion of the strip along the longitudinal axis of the strip,
      • only a portion of the outer surface is bonded to the inner surface of the outer structure, and
      • when the catheter is bent along its longitudinal axis, the second portion is configured to slide relative to the first portion.


8. The catheter of example 7, wherein the inner structure includes over-lapping edges.


9. The catheter of example 7 or example 8, wherein the inner structure is non-continuous in a longitudinal direction.


10. The catheter of any one of examples 7-9, wherein the inner structure provides less than 50% of the total bending stiffness of the catheter.


11. The catheter of any one of examples 7-10, wherein the first portion slides tangentially relative to the second portion during bending of the catheter.


12. The catheter of any one of examples 7-11, wherein the strip of material is formed from a polymer tube that has been cut in a direction parallel to a longitudinal axis of the tube.


13. the catheter of any one of examples 7-11, wherein the strip of material is formed from a polymer tube that has been cut in a helical direction.


14. The catheter of any one of examples 7-13, wherein the polymer tube has an etched exterior surface and an inner surface that is not etched.


14. The catheter of any one of examples 7-13, wherein the polymer tube is a PTFE tube.


V. CONCLUSION

Many embodiments of the present technology can be used to access or treat targets located in tortuous and narrow vessels, such as certain sites in the neurovascular system, the pulmonary vascular system, the coronary vascular system, and/or the peripheral vascular system. The catheter shaft of the present technology can also be suited for use in the digestive system, soft tissues, and/or any other insertion into an organism for medical uses.


It will be appreciated that specific elements, substructures, advantages, uses, and/or other features of the embodiments described with reference to FIGS. 1A-4C can be suitably interchanged, substituted or otherwise configured with one another in accordance with additional embodiments of the present technology. For example, a single catheter shaft can include an inner structure having a helical portion (as shown in FIGS. 1A-2F) and a segmented portion (as shown in FIGS. 3A-4C). A person of ordinary skill in the art, therefore, will accordingly understand that the technology can have other embodiments with additional elements, or the technology can have other embodiments without several of the features shown and described above with reference to FIGS. 1A-4C. For example, the catheters of the present technology can be used with any of the clot treatment devices and associated devices, systems, and methods disclosed in U.S. patent application Ser. No. 14/299,933, filed Jun. 9, 2014, and U.S. patent application Ser. No. 13/843,742, filed Mar. 15, 2013, and U.S. patent application Ser. No. 14/735,110, filed Jun. 9, 2015, all of which are incorporated herein by reference in their entireties. Additionally, in some embodiments, the catheter shaft of the present technology can include additional structures and/or layers. For example, in a particular embodiment, the shaft includes an additional structure or material positioned between the inner structure and the outer structure. Moreover, in a particular embodiment, the shaft includes more than one strip.

Claims
  • 1. A catheter, comprising: a generally tubular outer structure; andan inner structure surrounded by the outer structure and that surrounds a catheter lumen, wherein the inner structure extends along a longitudinal axis and includes over-lapping edges that overlap in a radial direction relative to the longitudinal axis, wherein the overlapping edges extend entirely circumferentially about the longitudinal axis, and wherein the over-lapping edges are not adhered together.
  • 2. A catheter, comprising: a generally tubular outer structure; andan inner structure surrounded by the outer structure, wherein the inner structure is non-continuous in a longitudinal direction, wherein the inner structure has a freely sliding interface with itself in a radial direction relative to the longitudinal axis, and wherein the freely sliding interface extends entirely circumferentially about the longitudinal axis.
  • 3. A catheter, comprising: a generally tubular outer structure; andan inner structure surrounded by the outer structure, wherein the inner structure extends along a longitudinal axis, wherein the inner structure has freely sliding interfaces with itself in a radial direction relative to the longitudinal axis, and wherein the freely sliding interfaces extend entirely circumferentially about the longitudinal axis.
  • 4. A catheter, comprising: a generally tubular outer structure; andan innermost structure surrounded by the outer structure, wherein the innermost structure extends along a longitudinal axis, wherein the innermost structure provides less than 50% of the total bending stiffness of the catheter, wherein the inner structure has a freely sliding interface with itself in a radial direction relative to the longitudinal axis, and wherein the freely sliding interface extends entirely circumferentially about the longitudinal axis.
  • 5. A catheter, comprising a generally tubular outer structure; and an inner structure surrounded by the outer structure, wherein the inner structure extends along a longitudinal axis, wherein the inner structure has inner portions and outer portions that overlap in a radial direction relative to the longitudinal axis, wherein the inner portions and the outer portions overlap entirely circumferentially about the longitudinal axis, and wherein the inner portions are configured to slide tangentially relative to the outer portions during bending of the catheter.
  • 6. A catheter, comprising a generally tubular outer structure, the outer structure having an outer surface and an inner surface; and an inner structure surrounded by the outer structure, wherein the inner structure is composed of a strip of material that is helically wound around a central longitudinal axis to form a generally tubular member defining a lumen, wherein the strip has an outer surface and an inner surface, wherein the strip is wound to have an overlapping region at which a first portion of the strip overlaps a second portion of the strip in a radial direction relative to the longitudinal axis of the strip, and wherein, at the overlapping region of the strip the outer surface of the first portion of the strip is at least partially bonded to the inner surface of the outer structure, andthe outer surface of the first portion of the strip (a) faces the inner surface of the second portion of the strip and (b) is configured to slide relative to the inner surface of the first portion of the strip when the inner structure is bent relative to the longitudinal axis.
  • 7. The catheter of claim 3, wherein the outer structure has an outer surface and an inner surface; andthe inner structure has a relaxed state and a stressed state, and wherein the inner structure is composed of a strip of material that is helically wound around the longitudinal axis to form a generally tubular member defining a lumen, wherein the strip has an outer surface and an inner surface,a first portion of the strip overlaps a second portion of the strip along the longitudinal axis,only a portion of the outer surface of the inner structure is bonded to the inner surface of the outer structure, andwhen the inner structure is bent along the longitudinal axis, the second portion is configured to slide relative to the first portion.
  • 8. The catheter of claim 3 wherein the inner structure includes over-lapping edges.
  • 9. The catheter of claim 3 wherein the over-lapping edges are not bonded together.
  • 10. The catheter of claim 3 wherein the inner structure does not include an adhesive between the over-lapping edges.
  • 11. The catheter of claim 3 wherein the inner structure is composed of a strip of material that is helically wound around the longitudinal axis to form a generally tubular member defining a lumen.
  • 12. The catheter of claim 11 wherein the strip of material is formed from a polymer tube that has been cut in a direction parallel to a longitudinal axis of the tube.
  • 13. The catheter of claim 11 wherein the strip of material is formed from a polymer tube that has been cut in a helical direction.
  • 14. The catheter of claim 11 wherein the strip of material is formed from a polymer tube that has an etched exterior surface and an inner surface that is not etched.
  • 15. The catheter of claim 11 wherein the strip of material is formed from a PTFE tube.
  • 16. The catheter of claim 3 wherein the outer structure as an inner surface, wherein the inner structure has an outer surface, and wherein only a portion the outer surface of the inner structure is bonded to the inner surface of the outer structure.
  • 17. The catheter of claim 6 wherein the overlapping region extends entirely circumferentially about the longitudinal axis.
CROSS-REFERENCE TO RELATED APPLICATION(S)

This application is a 35 U.S.C. § National Phase application of International Patent Application No. PCT/US2016/067628, filed Dec. 19, 2016, which claims priority to U.S. Provisional Application No. 62/269,372, filed on Dec. 18, 2015, titled “CATHETER SHAFT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS,” the contents of which are hereby incorporated by reference in their entireties.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2016/067628 12/19/2016 WO
Publishing Document Publishing Date Country Kind
WO2017/106877 6/22/2017 WO A
US Referenced Citations (361)
Number Name Date Kind
2846179 Monckton Aug 1958 A
3088363 Sparks May 1963 A
3197173 Taubenheim Jul 1965 A
3435826 Fogarty Apr 1969 A
3892161 Sokol Jul 1975 A
3923065 Nozick et al. Dec 1975 A
4030503 Clark, III Jun 1977 A
4034642 Iannucci et al. Jul 1977 A
4287808 Leonard et al. Sep 1981 A
4393872 Reznik et al. Jul 1983 A
4523738 Raftis et al. Jun 1985 A
4551862 Haber Nov 1985 A
4650466 Luther Mar 1987 A
4873978 Ginsburg Oct 1989 A
4883458 Shiber Nov 1989 A
4890611 Monfort et al. Jan 1990 A
4960259 Sunnanvader et al. Oct 1990 A
4978341 Niederhauser Dec 1990 A
5011488 Ginsburg Apr 1991 A
5059178 Ya Oct 1991 A
5102415 Guenther et al. Apr 1992 A
5127626 Hilal et al. Jul 1992 A
5129910 Phan et al. Jul 1992 A
5192286 Phan et al. Mar 1993 A
5192290 Hilal Mar 1993 A
5360417 Gravener et al. Nov 1994 A
5370653 Cragg Dec 1994 A
5476450 Ruggio Dec 1995 A
5490859 Mische et al. Feb 1996 A
5591137 Stevens Jan 1997 A
5746758 Nordgren et al. May 1998 A
5749858 Cramer May 1998 A
5766191 Trerotola Jun 1998 A
5782817 Franzel et al. Jul 1998 A
5827229 Auth et al. Oct 1998 A
5827304 Hart Oct 1998 A
5868708 Hart et al. Feb 1999 A
5873866 Kondo et al. Feb 1999 A
5873882 Straub et al. Feb 1999 A
5876414 Straub Mar 1999 A
5882329 Patterson et al. Mar 1999 A
5911710 Barry et al. Jun 1999 A
5972019 Engelson et al. Oct 1999 A
5974938 Lloyd Nov 1999 A
5989233 Yoon Nov 1999 A
5993483 Gianotti Nov 1999 A
6066149 Samson et al. May 2000 A
6221006 Dubrul et al. Apr 2001 B1
6228060 Howell May 2001 B1
6238412 Dubrul et al. May 2001 B1
6254571 Hart Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6306163 Fitz Oct 2001 B1
6350271 Kurz et al. Feb 2002 B1
6364895 Greenhalgh Apr 2002 B1
6368339 Amplatz Apr 2002 B1
6383205 Samson et al. May 2002 B1
6413235 Parodi Jul 2002 B1
6423032 Parodi Jul 2002 B2
6440148 Shiber Aug 2002 B1
6454741 Muni et al. Sep 2002 B1
6454775 Demarais et al. Sep 2002 B1
6458103 Albert et al. Oct 2002 B1
6458139 Palmer et al. Oct 2002 B1
6511492 Rosenbluth et al. Jan 2003 B1
6514273 Voss et al. Feb 2003 B1
6530935 Wensel et al. Mar 2003 B2
6530939 Hopkins et al. Mar 2003 B1
6544279 Hopkins et al. Apr 2003 B1
6551342 Shen et al. Apr 2003 B1
6589263 Hopkins et al. Jul 2003 B1
6596011 Johnson et al. Jul 2003 B2
6602271 Adams et al. Aug 2003 B2
6605074 Zadno-Azizi et al. Aug 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6623460 Heck Sep 2003 B1
6635070 Leeflang et al. Oct 2003 B2
6645222 Parodi et al. Nov 2003 B1
6660013 Rabiner et al. Dec 2003 B2
6663650 Sepetka et al. Dec 2003 B2
6685722 Rosenbluth et al. Feb 2004 B1
6692504 Kurz et al. Feb 2004 B2
6699260 Dubrul et al. Mar 2004 B2
6755847 Eskuri Jun 2004 B2
6767353 Shiber Jul 2004 B1
6800080 Bates Oct 2004 B1
6824553 Gene et al. Nov 2004 B1
6939361 Kleshinski Sep 2005 B1
6960222 Vo et al. Nov 2005 B2
7004954 Voss et al. Feb 2006 B1
7036707 Aota et al. May 2006 B2
7041084 Fojtik May 2006 B2
7052500 Bashir et al. May 2006 B2
7056328 Arnott Jun 2006 B2
7069835 Nishri et al. Jul 2006 B2
7094249 Thomas et al. Aug 2006 B1
7179273 Palmer et al. Feb 2007 B1
7220269 Ansel et al. May 2007 B1
7232432 Fulton, III et al. Jun 2007 B2
7244243 Lary Jul 2007 B2
7285126 Sepetka et al. Oct 2007 B2
7306618 Demond et al. Dec 2007 B2
7320698 Eskuri Jan 2008 B2
7323002 Johnson et al. Jan 2008 B2
7331980 Dubrul et al. Feb 2008 B2
7534234 Fojtik May 2009 B2
7578830 Kusleika et al. Aug 2009 B2
7621870 Berrada et al. Nov 2009 B2
7674247 Fojtik Mar 2010 B2
7691121 Rosenbluth et al. Apr 2010 B2
7695458 Belley et al. Apr 2010 B2
7763010 Evans et al. Jul 2010 B2
7766934 Pal et al. Aug 2010 B2
7775501 Kees Aug 2010 B2
7905877 Oscar et al. Mar 2011 B1
7905896 Straub Mar 2011 B2
7938809 Lampropoulos et al. May 2011 B2
7938820 Webster et al. May 2011 B2
7967790 Whiting et al. Jun 2011 B2
7976511 Fojtik Jul 2011 B2
7993302 Hebert et al. Aug 2011 B2
7993363 Demond et al. Aug 2011 B2
8043313 Krolik et al. Oct 2011 B2
8052640 Fiorella et al. Nov 2011 B2
8066757 Ferrera et al. Nov 2011 B2
8070791 Ferrera et al. Dec 2011 B2
8075510 Aklog et al. Dec 2011 B2
8088140 Ferrera et al. Jan 2012 B2
8100935 Rosenbluth et al. Jan 2012 B2
8109962 Pal Feb 2012 B2
8118829 Carrison et al. Feb 2012 B2
8197493 Ferrera et al. Jun 2012 B2
8246641 Osborne et al. Aug 2012 B2
8261648 Marchand et al. Sep 2012 B1
8267897 Wells Sep 2012 B2
8298257 Sepetka et al. Oct 2012 B2
8317748 Fiorella et al. Nov 2012 B2
8337450 Fojtik Dec 2012 B2
RE43902 Hopkins et al. Jan 2013 E
8357178 Grandfield et al. Jan 2013 B2
8361104 Jones et al. Jan 2013 B2
8409215 Sepetka et al. Apr 2013 B2
8486105 Demond et al. Jul 2013 B2
8491539 Fojtik Jul 2013 B2
8512352 Martin Aug 2013 B2
8535334 Martin Sep 2013 B2
8545526 Martin et al. Oct 2013 B2
8568432 Straub Oct 2013 B2
8574262 Ferrera et al. Nov 2013 B2
8579915 French et al. Nov 2013 B2
8585713 Ferrera et al. Nov 2013 B2
8696622 Fiorella et al. Apr 2014 B2
8715314 Janardhan et al. May 2014 B1
8771289 Mohiuddin et al. Jul 2014 B2
8777893 Malewicz Jul 2014 B2
8784434 Rosenbluth et al. Jul 2014 B2
8784441 Rosenbluth et al. Jul 2014 B2
8795305 Martin et al. Aug 2014 B2
8795345 Grandfield et al. Aug 2014 B2
8801748 Martin Aug 2014 B2
8814927 Shin et al. Aug 2014 B2
8820207 Marchand et al. Sep 2014 B2
8826791 Thompson et al. Sep 2014 B2
8828044 Aggerholm et al. Sep 2014 B2
8833224 Thompson et al. Sep 2014 B2
8845621 Fojtik Sep 2014 B2
8852205 Brady et al. Oct 2014 B2
8852226 Gilson et al. Oct 2014 B2
8932319 Martin et al. Jan 2015 B2
8939991 Krolik et al. Jan 2015 B2
8945143 Ferrera et al. Feb 2015 B2
8945172 Ferrera et al. Feb 2015 B2
8968330 Rosenbluth et al. Mar 2015 B2
8992504 Castella et al. Mar 2015 B2
9005172 Chung Apr 2015 B2
9101382 Krolik et al. Aug 2015 B2
9149609 Ansel et al. Oct 2015 B2
9161766 Slee et al. Oct 2015 B2
9204887 Cully et al. Dec 2015 B2
9259237 Quick et al. Feb 2016 B2
9283066 Hopkins et al. Mar 2016 B2
9408620 Rosenbluth Aug 2016 B2
9439664 Sos Sep 2016 B2
9439751 White et al. Sep 2016 B2
9456834 Folk Oct 2016 B2
9463036 Brady et al. Oct 2016 B2
9526864 Quick Dec 2016 B2
9526865 Quick Dec 2016 B2
9566424 Pessin Feb 2017 B2
9579116 Nguyen et al. Feb 2017 B1
9616213 Furnish et al. Apr 2017 B2
9636206 Nguyen et al. May 2017 B2
9700332 Marchand et al. Jul 2017 B2
9717519 Rosenbluth et al. Aug 2017 B2
9744024 Nguyen et al. Aug 2017 B2
9757137 Krolik et al. Sep 2017 B2
9844386 Nguyen et al. Dec 2017 B2
9844387 Marchand et al. Dec 2017 B2
9999493 Nguyen et al. Jun 2018 B2
10004531 Rosenbluth et al. Jun 2018 B2
10045790 Cox et al. Aug 2018 B2
10098651 Marchand et al. Oct 2018 B2
10226263 Look et al. Mar 2019 B2
10335186 Rosenbluth et al. Jul 2019 B2
10342571 Marchand et al. Jul 2019 B2
10349960 Quick Jul 2019 B2
10524811 Marchand et al. Jan 2020 B2
10588655 Rosenbluth et al. Mar 2020 B2
10912577 Marchand et al. Feb 2021 B2
11058445 Cox et al. Jul 2021 B2
11058451 Marchand et al. Jul 2021 B2
11147571 Cox et al. Oct 2021 B2
11154314 Quick Oct 2021 B2
20010004699 Gittings et al. Jun 2001 A1
20010041909 Tsugita et al. Nov 2001 A1
20010051810 Dubrul et al. Dec 2001 A1
20020095171 Belef Jul 2002 A1
20020111648 Kusleika et al. Aug 2002 A1
20020120277 Hauschild et al. Aug 2002 A1
20020147458 Hiblar et al. Oct 2002 A1
20020156457 Fisher Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20030114875 Sjostrom Jun 2003 A1
20030116731 Hartley Jun 2003 A1
20030125663 Coleman et al. Jul 2003 A1
20030135230 Massey et al. Jul 2003 A1
20030153973 Soun et al. Aug 2003 A1
20040039412 Isshiki et al. Feb 2004 A1
20040073243 Sepetka et al. Apr 2004 A1
20040138692 Phung et al. Jul 2004 A1
20040199202 Dubrul et al. Oct 2004 A1
20050038468 Panetta et al. Feb 2005 A1
20050119668 Teague et al. Jun 2005 A1
20050283165 Gadberry Dec 2005 A1
20050283186 Berrada et al. Dec 2005 A1
20060047286 West Mar 2006 A1
20060100662 Daniel et al. May 2006 A1
20060247500 Voegele et al. Nov 2006 A1
20060253145 Lucas Nov 2006 A1
20060282111 Morsi Dec 2006 A1
20070038225 Osborne Feb 2007 A1
20070112374 Paul, Jr. et al. May 2007 A1
20070118165 DeMello et al. May 2007 A1
20070161963 Smalling Jul 2007 A1
20070179513 Deutsch Aug 2007 A1
20070191866 Palmer et al. Aug 2007 A1
20070198028 Miloslavski et al. Aug 2007 A1
20070208361 Okushi et al. Sep 2007 A1
20070208367 Fiorella et al. Sep 2007 A1
20070213753 Waller Sep 2007 A1
20070255252 Mehta Nov 2007 A1
20080015541 Rosenbluth et al. Jan 2008 A1
20080088055 Ross Apr 2008 A1
20080157017 Macatangay et al. Jul 2008 A1
20080167678 Morsi Jul 2008 A1
20080228209 DeMello et al. Sep 2008 A1
20080234722 Bonnette et al. Sep 2008 A1
20080262528 Martin Oct 2008 A1
20080269798 Ramzipoor et al. Oct 2008 A1
20080300466 Gresham Dec 2008 A1
20090018566 Escudero et al. Jan 2009 A1
20090054918 Henson Feb 2009 A1
20090062841 Amplatz et al. Mar 2009 A1
20090160112 Ostrovsky Jun 2009 A1
20090163846 Aklog et al. Jun 2009 A1
20090182362 Thompson et al. Jul 2009 A1
20090281525 Harding et al. Nov 2009 A1
20090292307 Razack Nov 2009 A1
20100087850 Razack Apr 2010 A1
20100114113 Dubrul et al. May 2010 A1
20100121312 Gielenz et al. May 2010 A1
20100204712 Mallaby Aug 2010 A1
20100249815 Jantzen et al. Sep 2010 A1
20100318178 Rapaport et al. Dec 2010 A1
20110054405 Whiting et al. Mar 2011 A1
20110060212 Slee et al. Mar 2011 A1
20110125181 Brady et al. May 2011 A1
20110144592 Wong et al. Jun 2011 A1
20110152823 Mohiuddin et al. Jun 2011 A1
20110152993 Marchand et al. Jun 2011 A1
20110160742 Ferrera et al. Jun 2011 A1
20110160763 Ferrera et al. Jun 2011 A1
20110190806 Wittens Aug 2011 A1
20110213290 Chin et al. Sep 2011 A1
20110213403 Aboytes Sep 2011 A1
20110224707 Miloslavski et al. Sep 2011 A1
20110245807 Sakata Oct 2011 A1
20110251629 Galdonik et al. Oct 2011 A1
20110264133 Hanlon et al. Oct 2011 A1
20110319917 David et al. Dec 2011 A1
20120059356 di Palma et al. Mar 2012 A1
20120089216 Rapaport et al. Apr 2012 A1
20120101480 Ingle Apr 2012 A1
20120101510 Lenker et al. Apr 2012 A1
20120138832 Townsend Jun 2012 A1
20120143239 Aklog et al. Jun 2012 A1
20120165919 Cox et al. Jun 2012 A1
20120179181 Straub et al. Jul 2012 A1
20120232655 Lorrison et al. Sep 2012 A1
20120271231 Agrawal Oct 2012 A1
20120310166 Huff Dec 2012 A1
20130030460 Marks et al. Jan 2013 A1
20130092012 Marchand et al. Apr 2013 A1
20130102996 Strauss Apr 2013 A1
20130184703 Brice et al. Jul 2013 A1
20130289608 Tanaka et al. Oct 2013 A1
20140005713 Bowman Jan 2014 A1
20140025048 Ward Jan 2014 A1
20140155830 Bonnette et al. Jun 2014 A1
20140276403 Follmer et al. Sep 2014 A1
20140371779 Vale et al. Dec 2014 A1
20150018860 Quick et al. Jan 2015 A1
20150025555 Sos Jan 2015 A1
20150032144 Holloway Jan 2015 A1
20150059908 Mollen Mar 2015 A1
20150133990 Davidson May 2015 A1
20150196744 Aboytes Jul 2015 A1
20150238207 Cox et al. Aug 2015 A1
20150265299 Cooper et al. Sep 2015 A1
20150305756 Rosenbluth et al. Oct 2015 A1
20150305859 Eller Oct 2015 A1
20150352325 Quick Dec 2015 A1
20150360001 Quick Dec 2015 A1
20150374391 Quick et al. Dec 2015 A1
20160113666 Quick et al. Apr 2016 A1
20160143721 Rosenbluth et al. May 2016 A1
20160206344 Bruzzi et al. Jul 2016 A1
20160262790 Rosenbluth et al. Sep 2016 A1
20160277276 Cox et al. Oct 2016 A1
20170014560 Minskoff et al. Jan 2017 A1
20170037548 Lee Feb 2017 A1
20170058623 Jaffrey et al. Mar 2017 A1
20170105745 Rosenbluth et al. Apr 2017 A1
20170112514 Marchand et al. Apr 2017 A1
20170189041 Cox et al. Jul 2017 A1
20170233908 Kroczynski et al. Aug 2017 A1
20170265878 Marchand et al. Sep 2017 A1
20170325839 Rosenbluth et al. Nov 2017 A1
20180064453 Garrison et al. Mar 2018 A1
20180064454 Losordo et al. Mar 2018 A1
20180092652 Marchand et al. Apr 2018 A1
20180105963 Quick Apr 2018 A1
20180125512 Nguyen et al. May 2018 A1
20180193043 Marchand et al. Jul 2018 A1
20180256178 Cox et al. Sep 2018 A1
20180296240 Rosenbluth et al. Oct 2018 A1
20180344339 Cox et al. Dec 2018 A1
20190000492 Casey et al. Jan 2019 A1
20190070401 Merritt et al. Mar 2019 A1
20190150959 Cox et al. May 2019 A1
20190231373 Quick Aug 2019 A1
20190321071 Marchand et al. Oct 2019 A1
20200046368 Merritt et al. Feb 2020 A1
20210113224 Dinh Apr 2021 A1
20210186541 Thress Jun 2021 A1
20210290925 Merritt et al. Sep 2021 A1
20210330344 Rosenbluth et al. Oct 2021 A1
20210378694 Thress et al. Dec 2021 A1
20220000505 Hauser Jan 2022 A1
20220000506 Hauser Jan 2022 A1
20220000507 Hauser Jan 2022 A1
Foreign Referenced Citations (53)
Number Date Country
103932756 Jul 2014 CN
6190049 Jul 1994 JP
H07323090 Dec 1995 JP
2001522631 May 1999 JP
2004097807 Apr 2004 JP
2005230132 Sep 2005 JP
2005323702 Nov 2005 JP
2006094876 Apr 2006 JP
2011526820 Jan 2010 JP
WO-1997017889 May 1997 WO
WO-1999044542 Sep 1999 WO
WO-2000053120 Sep 2000 WO
WO2004018916 Mar 2004 WO
WO-2005046736 May 2005 WO
WO-2006110186 Oct 2006 WO
WO-2007092820 Aug 2007 WO
WO2009082513 Jul 2009 WO
WO-20091 55571 Dec 2009 WO
WO-2009155571 Dec 2009 WO
WO2010002549 Jan 2010 WO
WO-2010010545 Jan 2010 WO
WO-201 0023671 Mar 2010 WO
WO-2010023671 Mar 2010 WO
WO-201 0049121 May 2010 WO
WO-2010049121 May 2010 WO
WO-201 0102307 Sep 2010 WO
WO-2010102307 Sep 2010 WO
WO2011032712 Mar 2011 WO
WO-2011054531 May 2011 WO
WO-2012009675 Jan 2012 WO
WO-201 2011097 Apr 2012 WO
WO-2012011097 Apr 2012 WO
WO-201 2065748 May 2012 WO
WO-2012065748 May 2012 WO
WO2012120490 Sep 2012 WO
WO-2014047650 Mar 2014 WO
WO-2014081892 May 2014 WO
WO-2015006782 Jan 2015 WO
WO-2015061365 Apr 2015 WO
WO2015121424 Aug 2015 WO
WO2015191646 Dec 2015 WO
WO2017024258 Feb 2017 WO
WQ2017024258 Feb 2017 WO
WO2017070702 Apr 2017 WO
WQ2017070702 Apr 2017 WO
WO2017106877 Jun 2017 WO
WO2018080590 May 2018 WO
WQ2018080590 May 2018 WO
WO2018148174 Aug 2018 WO
WO2019050765 Mar 2019 WO
WO2019075444 Apr 2019 WO
WO2020036809 Feb 2020 WO
WO2021248042 Dec 2021 WO
Non-Patent Literature Citations (58)
Entry
International Search Report and Written Opinion for International App. No. PCT/US2015/034987, dated Jun. 9, 2015, 12 pages.
International Search Report and Written Opinion for International Application No. PCT/US2015/034987, dated Sep. 17, 2015, 12 pages.
International Search Report for International App. No. PCT/US13/71101, dated Mar. 31, 2014, 4 pages.
Konstantinides, S. et al., “Pulmonary embolism hotline 2012—Recent and expected trials”, Thrombosis and Haemostasis, Jan. 9, 2013:33; 43-50.
Konstantinides, S. et al., “Pulmonary embolism: risk assessment and management”, European Society of Cardiology; European Heart Journal, Sep. 7, 2012:33, 3014-3022.
Kucher, N. et al., “Percutaneous Catheter Thrombectomy Device for Acute Pulmonary Embolism: In Vitro and in Vivo Testing”, Circulation, Sep. 2005:112:e28-e32.
Kucher, N., “Catheter Interventions in Massive Pulmonary Embolism”, CardiologyRounds, Mar. 2006 vol. 10, Issue 3, 6 pages.
Kucher, N. et al., “Management of Massive Pulmonary Embolism”, Radiology, Sep. 2005:236:3 852-858.
Kucher, N. et al., “Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism.” Circulation, 2014, 129, pp. 9 pages.
Kuo, W. et al., “Catheter-directed Therapy for the Treatment of Massive Pulmonary Embolism: Systematic Review and Meta-analysis of Modern Techniques”, Journal of Vascular and Interventional Radiology, Nov. 2009:20:1431-1440.
Kuo, W. et al., “Catheter-Directed Embolectomy, Fragmentation, and Thrombolysis for the Treatment of Massive Pulmonary Embolism After Failure of Systemic Thrombolysis”, American College of CHEST Physicians 2008: 134:250-254.
Kuo, W. MD, “Endovascular Therapy for Acute Pulmonary Embolism”, Continuing Medical Education Society of Interventional Radiology (“CME”); Journal of Vascular and Interventional Radiology, Feb. 2012: 23:167-179.
Lee, L. et al., “Massive pulmonary embolism: review of management strategies with a focus on catheter- based techniques”, Expert Rev. Cardiovasc. Ther. 8(6), 863-873 (2010).
Liu, S. et al., “Massive Pulmonary Embolism: Treatment with the Rotarex Thrombectomy System”, Cardiovascular Interventional Radiology; 2011: 34:106-113.
Muller-Hulsbeck, S. et al. “Mechanical Thrombectomy of Major and Massive Pulmonary Embolism with Use of the Amplatz Thrombectomy Device”, Investigative Radiology, Jun. 2001:36:6:317-322.
Notice of Allowance for U.S. Appl. No. 13/843,742, dated Mar. 12, 2014, 13 pages.
Notice of Allowance for U.S. Appl. No. 14/288,778, dated Dec. 23, 2014, 12 pages.
Reekers, J. et al., “Mechanical Thrombectomy for Early Treatment of Massive Pulmonary Embolism”, CardioVascular and Interventional Radiology, 2003: 26:246-250.
Schmitz-Rode et al., “New Mesh Basket for Percutaneous Removal of Wall-Adherent Thrombi in Dialysis Shunts,” Cardiovasc Intervent Radiol 16:7-10 1993 4 pgs.
Schmitz-Rode et al., “Temporary Pulmonary Stent Placement as Emergency Treatment of Pulmonary Embolism,” Journal of the American College of Cardiology, vol. 48, No. 4, 2006 (5 pgs.).
Schmitz-Rode, T. et al., “Massive Pulmonary Embolism: Percutaneous Emergency Treatment by Pigtail Rotation Catheter”, JACC Journal of the American College of Cardiology, Aug. 2000:36:2:375-380.
Spiotta, A et al., “Evolution of thrombectomy approaches and devices for acute stroke: a technical review.” J NeuroIntervent Surg 2015, 7, pp. 7 pages.
Svilaas, T, et al., “Thrombus Aspiration During Primary Percutaneous Coronary Intervention.” The New England Journal of Medicine, 2008, vol. 358, No. 6, 11 pages.
Tapson, V., “Acute Pulmonary Embolism”, The New England Journal of Medicine, Mar. 6, 2008:358:2037-52.
The Penumbra Pivotal Stroke Trial Investigators, “The Penumbra Pivotal Stroke Trial: Safety and Effectiveness of a New Generation of Mechanical Devices for Clot Removal in Intracranial Large Vessel Occlusive Disease.” Stroke, 2009, 40: p. 9 pages.
Truong et al., “Mechanical Thrombectomy of Iliocaval Thrombosis Using a Protective Expandable Sheath,” Cardiovasc Intervent Radiol27-254-258, 2004, 5 pgs.
Turk et al., “Adapt Fast study: a direct aspiration first pass technique for acute stroke thrombectomy.” J NeuroIntervent Surg, vol. 6, 2014, 6 pages.
Uflacker, R., “Interventional Therapy for Pulmonary Embolism”, Journal of Vascular and Interventional Radiology, Feb. 2001: 12:147-164.
Verma, R., MD et al. “Evaluation of a Newly Developed Percutaneous Thrombectomy Basket Device in Sheep With Central Pulmonary Embolisms”, Investigative Raiology, Oct. 2006, 41, 729-734.
International Search Report and Written Opinion for International App. No. PCT/US2015/034987 filed Jun. 9, 2015, Applicant: Inceptus Medical, LLC, dated Sep. 17, 2015, 12 pages.
English translation of Japanese Office Action received for JP Application No. 2016-564210, Applicant: Inceptus Medical, LLC, dated Sep. 4, 2017, 4 pages.
Australian Exam Report received for AU Application No. 2015274704, Applicant: Inceptus Medical, LLC, dated Sep. 7, 2017, 3 pages.
European Search Report received for EP Application No. 15805810.7, Applicant: Inceptus Medical, LLC, dated Sep. 4, 2017, 6 pages.
International Search Report and Written Opinion for International App. No. PCT/US2016/067628 filed Dec. 19, 2016, Applicant: Inari Medical, Inc, dated Apr. 10, 2017, 11 pages.
International Search Report and Written Opinion for International App. No. PCT/US2017/029696, dated Apr. 26, 2017, Applicant: Inari Medical, Inc, dated Sep. 15, 2017, 19 pages.
International Search Report and Written Opinion for International App. No. PCT/US2016/058536, Date of Filing: Oct. 24, 2016, Applicant: Inari Medical, Inc, dated Mar. 13, 2017, 14 pages.
European Patent Application No. 13838945.7, Extended European Search Report, 9 pages, Apr. 15, 2016.
Gibbs, et al., “Temporary Stent as a bail-out device during percutaneous transluminal coronary angioplasty: preliminary clinical experience,” British Heart Journal, 1994, 71:372-377, Oct. 12, 1993 6 pgs.
Goldhaber, S. et al. “Percutaneous Mechanical Thrombectomy for Acute Pulmonary Embolism—A Double-Edged Sword”, American College of CHEST Physicians, Aug. 2007: 132:2, 363-372.
Goldhaber, S., “Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomy”, Journal of Thrombosis and Haemostasis, 2009: 7 (Suppl. 1): 322-327.
Gupta, S. et al., “Acute Pulmonary Embolism Advances in Treatment,” JAPI, Association of Physicians India, Mar. 2008, vol. 56, 185-191.
International Search Report and Written Opinion for International App. No. PCT/US13/61470, dated Jan. 17, 2014, 7 pages.
International Search Report and Written Opinion for International App. No. PCT/US2014/046567, dated Nov. 3, 2014, 13 pages.
International Search Report and Written Opinion for International App. No. PCT/US2014/061645, dated Jan. 23, 2015, 15 pages.
International Search Report and Written Opinion for International App. No. PCT/US2017/029696, Date of Filing: Apr. 26, 2017, Applicant: Inari Medical, Inc, dated Sep. 15, 2017, 19 pages.
European First Office Action received for EP Application No. 13838945.7, Applicant: Inari Medical, Inc., dated Oct. 26, 2018, 7 pages.
International Search Report and Written Opinion for International App. No. PCT/US2018/048786, Date of Filing: Aug. 30, 2018, Applicant: Inari Medical, Inc., dated Dec. 13, 2018, 12 pages.
International Search Report and Written Opinion for International App. No. PCT/US2018/055780, Date of Filing: Oct. 13, 2018, Applicant: Inceptus Medical LLC., dated Jan. 22, 2019, 8 pages.
European Search Report for European Application No. 16876941.2, Date of Filing: Dec. 19, 2016, Applicant: Inari Medical, Inc., dated Jul. 18, 2019, 7 pages.
Extended European Search Report for European Application No. 16858462.1, Date of Filing: Oct. 24, 2016, Applicant: Inari Medical, Inc., dated Jun. 3, 2019, 10 pages.
International Search Report and Written Opinion for International App. No. PCT/US2019/045794, Date of Filing: Aug. 8, 2019, Applicant: Inari Medical, Inc., dated Nov. 1, 2019, 17 pages.
Partial Supplementary European Search Report for European Application No. 17864818.4, Date of Filing: May 21, 2019, Applicant: Inari Medical, Inc., dated Apr. 24, 2020, 12 pages.
International Search Report and Written Opinion for International App. No. PCT/US2020/056067, Date of Filing: Oct. 16, 2020; Applicant: Inari Medical, Inc., dated Jan. 22, 2021, 8 pages.
Extended European Search Report for European Application No. 20191581.6, Applicant: Inari Medical, Inc., dated Mar. 31, 2021, 11 pages.
International Search Report and Written Opinion for International App. No. PCT/US2020/055645, Date of Filing: Dec. 17, 2020; Applicant: Inari Medical, Inc., dated Apr. 14, 2021, 12 pages.
Extended European Search Report for European Application No. 18853465.5, Applicant: Inari Medical, Inc., dated May 7, 2021, 2021, 7 pages.
International Search Report and Written Opinion for International App. No. PCT/US21/35965, Date of Filing: Jun. 4, 2021, Applicant: Inari Medical, Inc., dated Sep. 28, 2021, 12 pages.
English translation of Japanese Office action dated May 2, 2022 for Japanese Application No. 2018-531067, 3 pages.
Related Publications (1)
Number Date Country
20180361116 A1 Dec 2018 US
Provisional Applications (1)
Number Date Country
62269372 Dec 2015 US